ICA 069673
|
|
ICA 069673 Eigenschaften
- Siedepunkt:
- 358.9±37.0 °C(Predicted)
- Dichte
- 1.539±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- L?slichkeit
- DNF:30.0(Max Conc. mg/mL);111.26(Max Conc. mM)
DMSO:36.24(Max Conc. mg/mL);134.4(Max Conc. mM)
Ethanol:30.25(Max Conc. mg/mL);112.18(Max Conc. mM)
- Aggregatzustand
- Powder
- pka
- 9.47±0.70(Predicted)
- Farbe
- White to off-white
- InChI
- 1S/C11H6ClF2N3O/c12-11-15-4-7(5-16-11)17-10(18)6-1-2-8(13)9(14)3-6/h1-5H,(H,17,18)
- InChIKey
- IIBSHMFXVWTQSJ-UHFFFAOYSA-N
- SMILES
- O=C(C1=CC=C(F)C(F)=C1)NC2=CN=C(Cl)N=C2
Sicherheit
| WGK Germany | WGK 3 | ||
|---|---|---|---|
| Speicherklasse | 11 - Combustible Solids |
ICA 069673 Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
ICA 069673 is a heteromeric Kv7 channel activator. It is selective for Kv7.2/7.3 over Kv7.3/7.5 (EC50s = 0.69 and 14.3 μM, respectively) and also activates Kv7.4, Kv7.5, and heteromeric Kv7.4/7.5 channels in a dose-dependent manner. ICA 069673 has no activity against hERG, Nav1.5, and Kv7.1 cardiac ion channels (IC50s = >30 μM). Oral administration of ICA 069673 increases latency to first tonic-clonic seizure in the rat maximal electroshock and pentylentetrazol-induced seizure models (ED50s = 1.5 and <1 mg/kg, respectively). Formulations containing ICA 069673 are under clinical investigation for the treatment of epilepsy.ICA 069673 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
ICA 069673 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 79)Lieferanten
| Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
|---|---|---|---|---|---|
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32998 | 60 |
| BOC Sciences | +1-631-485-4226 |
inquiry@bocsci.com | United States | 19935 | 58 |
| Career Henan Chemica Co | +86-0371-86658258 +86-13203830695 |
laboratory@coreychem.com | China | 30203 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 |
sales@invivochem.cn | United States | 6378 | 58 |
| HANGZHOU LEAP CHEM CO., LTD. | +86-571-87711850 +8619957148339 |
market18@leapchem.com | China | 24569 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; |
support@targetmol.com | United States | 38999 | 58 |
| ShenZhen Trendseen Biological Technology Co.,Ltd. | 13417589054 |
trendseenbio@gmail.com | China | 11674 | 58 |
| Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +86-15965530500 |
nickzhang@hangyubiotech.com | China | 9935 | 58 |
| Aladdin Scientific | |
tp@aladdinsci.com | United States | 57473 | 58 |
| Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131885 | 58 |
- ICA 069673
- N-(2-Chloro-5-pyrimidinyl)-3,4-difluorobenzamide
- ICA069673;ICA-069673
- Benzamide, N-(2-chloro-5-pyrimidinyl)-3,4-difluoro-
- ICA-069673 >=98% (HPLC)
- Potassium Channel,ICA 069673,ICA-069673,KcsA,inhibit,Inhibitor
- N-(2-Chloropyrimidin-5-yl)-3,4-difluorobenzamide
- ICA-069673, 10 mM in DMSO
- ICA 069673 ,S0144
- 582323-16-8
- C11H6ClF2N3O
- Selective KCNQ2/Q3 potassium channel opener.




